Farmacoriflessioni
L’uso del TOBI nei pazienti con fibrosi cistica
FEDERICO MARCHETTI, NICOLA D’ANDREA
Divisione di Pediatria e Neonatologia, Ospedale Civile di Matera
Gennaio 2002 - pagg. 51 -52
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Bibliografia
1. Borsje P, de Jongste JC, Mouton JW, Tiddens
hawm. Aerosol therapy in cystic fibrosis:
a survey of 54 CF centers. Pediatr Pulmonol
2000;30:368-76.
2. Dezateux C, Walters S, Balfour-Lynn I. Inhaled Corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2000 (2); D 001915.
3. Kearney CE, Wallis CE. Deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev 2000 (2):CD 001127.
4. Prober CG, Walson PD, Jones J and the Committee on Infectious Diseases and Committee on Drugs. Technical report: precautions regarding the use of aerosolized antibiotics. Pediatrics 2000;106 (6):1-6.
5. Ryan G, Mukhopadhyay S, Singh M. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2000 (2):CD001021.
6. Doring G, Conway SP, Heijerman HGM, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Resp J 2000;16 (4):749-67.
7. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340 (1):23-33.
8. Marchetti F, Candusso M, Assael BM, Faraguna D. Trattamento antibiotico precoce della colonizzazione da Pseudomonas aeruginosa nella fibrosi cistica: una revisione della lettertura. Riv Ital Pediatr 2001;27:59-66.
9. Cheng K, Smyth RL, Motley J, O’Hea U, Ashby D. Randomised controlled trials in CF (1966-1997) catorized by time, design and intervention. Pediatr Pulmonol 2000;29:1-7.
2. Dezateux C, Walters S, Balfour-Lynn I. Inhaled Corticosteroids for cystic fibrosis. Cochrane Database Syst Rev 2000 (2); D 001915.
3. Kearney CE, Wallis CE. Deoxyribonuclease for cystic fibrosis. Cochrane Database Syst Rev 2000 (2):CD 001127.
4. Prober CG, Walson PD, Jones J and the Committee on Infectious Diseases and Committee on Drugs. Technical report: precautions regarding the use of aerosolized antibiotics. Pediatrics 2000;106 (6):1-6.
5. Ryan G, Mukhopadhyay S, Singh M. Nebulised anti-pseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2000 (2):CD001021.
6. Doring G, Conway SP, Heijerman HGM, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Resp J 2000;16 (4):749-67.
7. Ramsey BW, Pepe MS, Quan JM, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340 (1):23-33.
8. Marchetti F, Candusso M, Assael BM, Faraguna D. Trattamento antibiotico precoce della colonizzazione da Pseudomonas aeruginosa nella fibrosi cistica: una revisione della lettertura. Riv Ital Pediatr 2001;27:59-66.
9. Cheng K, Smyth RL, Motley J, O’Hea U, Ashby D. Randomised controlled trials in CF (1966-1997) catorized by time, design and intervention. Pediatr Pulmonol 2000;29:1-7.